Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001108205-25-000006
Filing Date
2025-01-30
Accepted
2025-01-30 16:03:48
Documents
1
Period of Report
2025-01-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1738271021.html 4  
1 FORM 4 wk-form4_1738271021.xml 4 3780
  Complete submission text file 0001108205-25-000006.txt   5293
Mailing Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421 617-503-6500
CURIS INC (Issuer) CIK: 0001108205 (see all company filings)

EIN.: 043505116 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O DIMENSION THERAPEUTICS, INC. 840 MEMORIAL DRIVE 4TH FLOOR CAMBRIDGE MA 02139
Business Address
Hohneker John (Reporting) CIK: 0001695378 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30347 | Film No.: 25573615